RNA Formulation Solutions
- 
                    The Power Of One: mRNA Services
                    We offer mRNA drug substance, formulated bulk drug product manufacturing (encapsulation), and fill/finish from a single site. 
- 
                    Contract Services To Optimize Continuous Nanoparticle Processing
                        10/16/2025
                    DIANT Pharma provides continuous manufacturing systems and technical services for nanoparticle-based formulations. The company’s platform supports both research and manufacturing teams working on lipid nanoparticles (LNPs), liposomes, polymeric micelles, nucleic acid–lipid complexes, and other colloidal systems. 
- 
                    CD34+ HSC LNP Kits
                        4/24/2025
                    Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications. 
- 
                    in vivo-jetRNA®+
                        9/14/2022
                    Efficient: 100% mRNA encapsulation leading to comparable LNP delivery results 
 in vivo-jetRNA®+ is the reagent of choice to deliver mRNA to various organs. This is attributable to its intrinsic properties: in vivo-jetRNA®+ protects its payload against ubiquitous endonucleases, prevent non-specific interactions with proteins and promote efficient cell entry.
- 
                    NanoAssemblr® Spark™: Freedom To Discover
                        4/14/2022
                    The NanoAssemblr® Spark™ is ideal for nanomedicine formulation discovery and screening at microliter scales. 
- 
                    Complete Solutions For Every Step Of Pharmaceutical Development
                        1/12/2023
                    By combining disruptive technology platforms with unparalleled genomic medicine development expertise, we're positioned to accelerate the development of LNP formulations and drug products. 
- 
                    Non-Viral Gene Delivery (NVGD) Using Polymeric-Nano Particles
                    Examine a NVGD platform that tackles the primary obstacle hindering gene editing therapies: efficient delivery. Utilizing engineered nanoparticles, the platform overcomes limitations associated with payload size. 
- 
                    Accelerating Gene Therapy With The HIT SCAN Platform
                        4/7/2025
                    Battelle’s HIT SCAN™ platform accelerates gene therapy by using high-throughput methods to design, screen, and optimize polymer nanoparticles (PNPs) for effective, non-viral delivery. 
- 
                    Non-Viral In Vivo Transfection - Cationic Lipids For LNP Formulation
                        7/13/2023
                    LipidBrick® IM21.7c - Efficient: Modulates LNP properties to adapt the biodistribution depending on the therapeutic purpose
- Secure: Use a unique lipid structure protected by an independent patent owned by Polyplus®
- Accelerate your project: in vitro and in vivo proof of concept have been successfully performed
 
- 
                    Measure The Size And Concentration Of Nanoparticles In Real Time
                        3/15/2024
                    Ideal tool for characterizing nanoparticles The Corning Videodrop utilizes the principles of interferometry in conjunction with microscopy to sense, detect, characterize, and track single nanoparticles in real time. The operation of this bioproduction analytical device is seamless thanks to its intuitive software interface and efficient sample handling protocol. 
